Coeptis Technologies Signs Binding Letter of Intent to Acquire Key Assets from a Risk Mitigation Software Company with 10,000 customers in over 100 countries, Expanding into the Booming Data Security Sector following the upcoming acquisition of NexGenAI Affiliates Network
WEXFORD, Pa., December 2024 /PRNewswire/: Coeptis Therapeutics Holdings, Inc. (Nasdaq: COEP) (the “Company” or “Coeptis”), a biopharmaceutical company focused on pioneering cell therapy platforms for cancer, autoimmune, and infectious diseases, is excited to announce the official launch of Coeptis Technologies, a new division aimed at diversifying and enhancing the company’s growth potential. This strategic move underscores Coeptis’ commitment to maximizing shareholder value and capitalizing on high-growth opportunities across different sectors.
In line with this initiative, Coeptis Technologies has signed a binding Letter of Intent (LOI) with a Risk Mitigation Software Company who is a leading company in the data security software industry with over 10,000 customers in over 100 countries. This LOI outlines the acquisition of significant technology assets, representing a key step in broadening our operational scope and entering the burgeoning data security market.
The acquisition will involve the transfer of their proprietary technologies, including its Data Placement Manager and Sensitive Content Manager solutions, to Coeptis’ newly established technology subsidiary. This development not only positions Coeptis as a formidable player in the data security field but also signals our dedication to innovation and long-term value creation for our shareholders. The transaction is anticipated to close upon the finalization of definitive agreements. The current President and CEO of the Risk Mitigation Software Company, will join Coeptis management team to lead this new technology division, ensuring that Coeptis leadership remains focused on both our biotechnology assets and the expansion into technology without distraction. This strategic move underscores Coeptis’ commitment to maximizing shareholder value and capitalizing on high-growth opportunities across different sectors.
Dave Mehalick, President and CEO of Coeptis Therapeutics, commented, “We are embarking on an exciting journey of expansion that will not only enhance our presence in the biopharmaceutical sector but also venture into the high-growth technology sector. By establishing Coeptis Technologies, we are strategically positioning ourselves to leverage the unique opportunities present in these two dynamic industries. Our commitment to deliver unprecedented value to our shareholders is stronger than ever as we pursue innovative solutions that address the evolving needs of the market.”
Dave Mehalick continued, “This acquisition represents a significant milestone in Coeptis’ strategic evolution. By integrating the high-value technology assets of this new acquisition, we are obtaining well-established, revenue-generating assets that will enable us to position ourselves for long-term growth in the rapidly expanding data security industry. The acquisition will keep our new technology team very busy in the coming months as they bring over 10,000 customers in over 100 countries to Coeptis Technologies and they provide a modern approach to data governance and security by identifying and protecting all sensitive data regardless of location, platform, or format. Their framework helps customers prioritize risk, identify security gaps, and implement effective data protection and privacy management strategies. The addition of these innovative data security solutions will not only diversify our portfolio but also allow us to explore new markets. We are particularly thrilled to welcome its CEO to our leadership team, as his expertise will be pivotal in maximizing the value of these assets and driving our next phase of growth, which aligns with our recently announced upcoming acquisition of NexGenAI Affiliates Network. More information on this acquisition will be announced in the coming weeks.”
Dave Mehalick also commented on the NexGenAI acquisition, stating, “We are excited to integrate NexGenAI Affiliates Network and its groundbreaking AI and RPA-driven tools into our new technology division. This integration is poised to enhance the performance of both our biotechnology and technology sectors. In highly competitive industries such as biotech, pharma, and MLM, where regulatory challenges are complex, having advanced tools to optimize marketing, streamline operations, and drive measurable results is not just beneficial—it’s essential for our success.”
The asset acquisition of the Risk Mitigation Software Company is subject to customary closing conditions, including the execution of definitive agreements and requisite approvals by both parties. Coeptis anticipates completing this transaction in early 2025.
This strategic expansion into Coeptis Technologies comes at a pivotal time when the technology sector continues to experience rapid growth, with many of the market’s top-performing stocks being technology-driven. By leveraging the innovative AI and RPA-driven tools from NexGenAI and the transformative data security technologies from the upcoming acquisition, Coeptis is not only diversifying its capabilities but is also positioning itself to thrive in one of the most dynamic and lucrative industries.
Also read: Viksit Workforce for a Viksit Bharat
Do Follow: The Mainstream formerly known as CIO News LinkedIn Account | The Mainstream formerly known as CIO News Facebook | The Mainstream formerly known as CIO News Youtube | The Mainstream formerly known as CIO News Twitter
About us:
The Mainstream formerly known as CIO News is the premier platform dedicated to delivering the latest news, updates, and insights from the CIO industry. As a trusted source in the technology and IT sector, we provide a comprehensive resource for executives and professionals seeking to stay informed and ahead of the curve. With a focus on cutting-edge developments and trends, The Mainstream formerly known as CIO News serves as your go-to destination for staying abreast of the rapidly evolving landscape of technology and IT. Founded in June 2020, The Mainstream formerly known as CIO News has rapidly evolved with ambitious growth plans to expand globally, targeting markets in the Middle East & Africa, ASEAN, USA, and the UK
